Standard Treatment Recommendations for Advanced Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NECs)

被引:0
|
作者
Smith, Abraham T. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
来源
JOURNAL OF THE PANCREAS | 2022年 / 23卷 / 07期
关键词
Pancreas; Pancreatitis; Pancreatic cell electrical activity; Insulin secretion;
D O I
10.35841/1590-8577-23.7.757
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NETs), also known as carcinoids and islet cell tumours, are tumours produced from neuroendocrine cells that can arise anywhere along the gastrointestinal system. They are a diverse family of neoplasms with a broad and complex clinical range. Neuroendocrine tumours are tumours that arise in neuroendocrine cells, which are specialized cells. Neuroendocrine cells share characteristics with nerve cells and hormone-producing cells. Neuroendocrine tumours are uncommon and can develop anywhere in the body. Endocrinol cells found in the gastroenteric mucosa as well as those found in the pancreas, mostly comprising islets of Langerhans, are referred to as Gastroenteropancreatic (GEP) endocrine cells.
引用
收藏
页码:68 / 69
页数:2
相关论文
共 50 条
  • [31] Management of advanced high grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): comprehensive review of the current literature
    Mohamed, A.
    Trybula, M.
    Asa, S. L.
    Halfdanarson, T. R.
    Sonbol, M. B.
    ENDOCRINE-RELATED CANCER, 2024, 31 (10)
  • [32] Pharmacodynamic evaluations of paired tumor biopsies in advanced neuroendocrine carcinomas (NECs) treated with the mTOR inhibitor temsirolimus.
    Duran, I
    Nicklee, T
    Siu, LL
    Birle, D
    Pond, GR
    Kortmansky, J
    Singh, D
    Hirte, H
    Goss, G
    Le, L
    Dancey, J
    Hedley, D
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9131S - 9131S
  • [33] Systemic Therapy in Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) and Ki Index 5-10%
    Jimenez-Fonseca, P.
    Carmona, A.
    Faez, L.
    Solis, P.
    Rodriguez, D.
    Ruiz, L.
    Sanchez, L.
    Li, W.
    Uriol, E.
    Menendez, M.
    Vieitez, J.
    Garrido, M.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 275 - 276
  • [34] Efficacy and Safety of Targeted Agents for Treatment of Gastroenteropancreatic (GEP) Neuroendocrine Tumor (NET): Single Center Experience
    Yoo, C.
    Cho, H.
    Kim, K.
    Chang, H. M.
    Kim, T.
    Hong, Y. S.
    Song, M. J.
    Hong, S. M.
    Kim, S.
    Ryoo, B. Y.
    NEUROENDOCRINOLOGY, 2016, 103 : 85 - 85
  • [35] Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data
    Abdel-Rahman, Omar
    Fouad, Mona
    TUMOR BIOLOGY, 2015, 36 (02) : 467 - 478
  • [37] Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?
    Rinke, Anja
    Auernhammer, Christoph J.
    Bodei, Lisa
    Kidd, Mark
    Krug, Sebastian
    Lawlor, Rita
    Marinoni, Ilaria
    Perren, Aurel
    Scarpa, Aldo
    Sorbye, Halfdan
    Pavel, Marianne Ellen
    Weber, Matthias M.
    Modlin, Irvin
    Gress, Thomas M.
    GUT, 2021, 70 (09) : 1768 - 1781
  • [38] PREDICTORS OF ANTIPROLIFERATIVE EFFECT OF LANREOTIDE AUTOGEL AS FIRST-LINE THERAPY FOR ADVANCED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOURS (GEP NET)
    Laskaratos, Faidon-Marios
    Megapanou, Maria
    Papantoniou, Dimitrios
    Hayes, Aimee R.
    von Stempel, Conrad
    Phillips, Edward
    Furnace, Myles
    Kousteni, Margarita
    Shah, Heer
    Mandair, Dalvinder
    Caplin, Martyn
    Toumpanakis, Christos
    GASTROENTEROLOGY, 2018, 154 (06) : S197 - S197
  • [39] Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature
    Abdel-Rahman, Omar
    Fouad, Mona
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (02) : 295 - 305
  • [40] Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature
    Omar Abdel-Rahman
    Mona Fouad
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 295 - 305